Lumida
/NKTR
⌘K
Nektar Therapeutics

Nektar Therapeutics

NKTR
$69.76USD-1.26%-0.89 today

MARKET CAP

2.4B

P/E (TTM)

FWD P/E

DAY RANGE

$68 – $71

52W RANGE

$33
$109

AI Summary

Stalk
StalkMedium

NKTR remains in a healthy Stage 2 uptrend above its 200‐day SMA with higher highs and lows, currently experiencing a volume‐light pullback into rising EMAs and the 50 SMA. Short‐term exhaustion and neutral RSI suggest patience, while the medium‐term bias stays bullish. Preferred engagement is on pullback acceptance around $70–72 or upon a sustained reclaim of the 9/20 EMAs.

  • Phase 2b REZOLVE-AD results indicate strong rezpegaldesleukin efficacy in moderate-to-severe atopic dermatitis.
  • A $1B cash and securities balance funds R&D and phase 3 trials through 2027.
  • Shares outstanding jumped from 14.1m to 33.1m, raising significant dilution concerns.
Full analysis →

Buying

7

institutions

Selling

8

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY2.94 M205.37 M+2.25 M+312.1%0.00%
MM

Millennium Management LLC

Q2 2026

BUY648.12 K45.25 M+243.84 K+55.5%0.02%
CA

Citadel Advisors LLC

Q2 2026

SELL499.05 K34.84 M+-166.38 K-27.2%0.00%
WP

Woodline Partners LP

Q2 2026

SELL470.88 K32.87 M+-359.80 K-45.0%0.10%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY244.18 K17.05 M+82.93 K+46.9%0.79%
AC

Aqr Capital Management LLC

Q2 2026

BUYNEW22.54 K1.57 M+22.54 K+0.0%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY21.46 K1.54 M+13.36 K+351.2%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL22.14 K1.54 M+-217.96 K-90.2%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL21.92 K1.53 M+-26.56 K-56.1%0.01%
FC

Farallon Capital Management LLC

Q1 2026

BUYNEW4.00 K287.80 K+4.00 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUYNEW200.0013.96 K+200.00+0.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-41.78 K-100.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-35.85 K-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-19.45 K-100.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-13.36 K-100.0%0.00%